Drug development strategy and company operations for early-stage life science ventures.

A Cambridge and London advisory for university spinouts and seed to Series A teams: development plans, investment readiness, grant funding and the operations that let the science do the talking.

Brian Sheehan, PhDDevelopment strategy and venture readiness

Lesley Sheehan, PhDOperations, grants and company build